Contact Now
Please Leave Us A Message
Privacy statement: Your privacy is very important to Us. Our company promises not to disclose your personal information to any external company with out your explicit permission.
Shaanxi Kaishi Biotechnology Co., Ltd
$40
1-199 Others
$30
200-499 Others
$20
≥500 Others
Product Description
Paclitaxel 98% is a high-purity pharmaceutical active pharmaceutical ingredient (API) widely used in oncology drug manufacturing and sterile injectable chemotherapy formulations. It is a natural diterpenoid compound originally derived from Taxus species and is a cornerstone molecule in modern anticancer therapy development.
As global demand continues to grow for advanced Pharmaceutical Enzymes, Nutritional Ingredients, and oncology-grade APIs, Paclitaxel 98% remains a critical raw material in GMP-certified pharmaceutical production, CDMO services, and injectable drug manufacturing.
Content Note: Prepared by our technical team based on peer-reviewed scientific literature. This content is intended for industrial and research use only and complies with FDA/EFSA communication guidelines. Last reviewed: June 2026
According to a study in Journal of Clinical Oncology (1998), paclitaxel demonstrated significant efficacy in the treatment of advanced ovarian and breast cancers as part of combination chemotherapy regimens.
According to a study in The New England Journal of Medicine (1994), paclitaxel showed meaningful clinical activity in previously treated ovarian cancer patients, supporting its role as a key chemotherapeutic agent.
Paclitaxel 98% is manufactured under strict GMP-controlled environments to ensure consistent purity, safety, and pharmaceutical-grade compliance for global markets.
| Parameter | Specification |
|---|---|
| Active Ingredient | Paclitaxel |
| Purity | ≥ 98% |
| Appearance | White to off-white crystalline powder |
| Test Method | HPLC |
| Form | API powder / injectable intermediate |
| Storage Condition | 2–8°C, protected from light |
The quality of Paclitaxel 98% depends on extraction method, purification technology, and GMP-certified manufacturing systems. Advanced production processes ensure high bioactivity and low impurity levels.
| Process Stage | Quality Impact |
|---|---|
| Plant-derived extraction (Taxus spp.) | Ensures natural structural integrity |
| Advanced chromatographic purification | Improves impurity profile and safety |
| Sterile processing and drying | Enhances stability for injectable use |
| API | Mechanism | Clinical Application |
|---|---|---|
| Paclitaxel | Microtubule stabilization | Breast, ovarian, lung cancers |
| Docetaxel | Microtubule stabilization | Solid tumor chemotherapy |
| Doxorubicin | DNA intercalation | Broad-spectrum oncology treatment |
Paclitaxel 98% is widely used in oncology pharmaceutical manufacturing and clinical drug development programs.
It is also utilized in research related to Plant Extracts , Standardized Extracts, Herbal Extracts , Antioxidants , and Superfood Powders for pharmaceutical innovation and formulation science.
We supply Paclitaxel 98% under strict GMP-certified systems with full regulatory support for global pharmaceutical markets.
It is used as an active pharmaceutical ingredient in chemotherapy drug production for cancer treatment.
Yes, it is commonly processed into sterile injectable dosage forms under GMP conditions.
The standard purity is ≥98%, confirmed by HPLC testing methods.
It should be stored at 2–8°C in a sealed, light-protected environment.
Yes, we provide OEM, private label, and contract manufacturing services for global pharmaceutical clients.
Packaging & Delivery
The file is encrypted. Please fill in the following information to continue accessing it
Privacy statement: Your privacy is very important to Us. Our company promises not to disclose your personal information to any external company with out your explicit permission.
Fill in more information so that we can get in touch with you faster
Privacy statement: Your privacy is very important to Us. Our company promises not to disclose your personal information to any external company with out your explicit permission.